KPIs & Operating Metrics(New)
Adjusted Operating Income By Segment AnnualAdjusted Operating Margin By Segment Annual %BacklogBacklog AnnualBreakdown Of AssetsBusiness Unit Revenue Drug DevelopmentCapital ExpenditureContractual Obligations TotalCost Of RevenuesDepreciation And Amortization By SegmentEmployeeGoodwill By SegmentGross Margin %Gross ProfitIncome Before Income Taxes By RegionNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Income By SegmentOperating Margin By Segment %Opex As A % Of Total Revenue %OPEX SegregationProperty, Plant And Equipment, Net BreakdownProperty, Plant And Equipment, Net By GeographyProperty, Plant And Equipment, Net By SegmentQuarterly Net Order Drug DevelopmentRemaining Performance ObligationsRemaining Performance Obligations AnnualRevenue By Base Business Diagnostics RevenueRevenue By Business VerticalRevenue By Business Vertical %Revenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By PayerRevenue By Payer %Revenue By Payer AnnualRevenue By Payer Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Revenue Mix Base Business Diagnostics Revenue %Revenue Per Employee %Revenuue Mix By Geography %Unearned Revenue
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Labcorp Holdings (LH) Gross Profit (2016 - 2025)

Labcorp Holdings' Gross Profit history spans 17 years, with the latest figure at $993.2 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 10.81% year-over-year to $993.2 million; the TTM value through Dec 2025 reached $4.0 billion, up 10.71%, while the annual FY2025 figure was $4.0 billion, 10.71% up from the prior year.
  • Gross Profit for Q4 2025 was $993.2 million at Labcorp Holdings, down from $1.0 billion in the prior quarter.
  • Across five years, Gross Profit topped out at $1.6 billion in Q1 2021 and bottomed at $743.1 million in Q4 2021.
  • The 5-year median for Gross Profit is $937.2 million (2024), against an average of $1.0 billion.
  • The largest YoY upside for Gross Profit was 119.64% in 2021 against a maximum downside of 60.99% in 2021.
  • A 5-year view of Gross Profit shows it stood at $743.1 million in 2021, then increased by 7.4% to $798.1 million in 2022, then rose by 2.92% to $821.4 million in 2023, then increased by 9.12% to $896.3 million in 2024, then rose by 10.81% to $993.2 million in 2025.
  • Per Business Quant, the three most recent readings for LH's Gross Profit are $993.2 million (Q4 2025), $1.0 billion (Q3 2025), and $1.0 billion (Q2 2025).